Mitochondria and diabetes mellitus: untangling a conflictive relationship?
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Summary: Diabetes mellitus is occasionally observed in patients with skeletal muscle respiratory chain deficiency, suggesting that skeletal muscle mitochondrial dysfunction might play a pathogenic role in type 2 diabetes (T2D). In support of this hypothesis, decreased muscle mitochondrial activity has been reported in T2D patients and in mouse models of diabetes. However, recent work by several groups suggests that decreased muscle mitochondrial function may be a consequence rather than a cause of diabetes, since decreased mitochondrial function in mice affords protection from diabetes and obesity. We review the data on this controversial but important issue of potential links between mitochondrial dysfunction and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · cited 1×
“Although proof is still lacking, thiazolidinediones probably exert skeletal muscle-specific effects, their main target being the adipocytes (Semple et al. 2006; Tontonoz and Spiegelman 2008).”
BackgroundMitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 5×
“In humans with T2D, the ability of insulin to inhibit hepatic gluconeogenesis is impaired (Petersen and Shulman 2006); and in T2D animal models, liver PGC-1a expression is elevated (Herzig et al. 2001; Koo et al. 2004; Saltiel and Kahn 2001; Yoon et al. 2001).”
BackgroundInfluentialBiochemical Adaptations in Muscle
Holloszy, J. O. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96046-1 · Cited by 1,517
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 1×
“Peroxisome proliferator-activated receptor g co-activator 1a (PGC1a) is the main stimulant of hepatic gluconeogenesis (Herzig et al. 2001; Saltiel and Kahn 2001; Yoon et al. 2001) and is inhibited by insulin (Li et al. 2007; Puigserver et al. 2003; Yoon et al. 2001).”
BackgroundKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 2×
“IMCL accumulation (particularly when related to a chronic high-fat diet) causes insulin resistance both in animal models (Kuhlmann et al. 2003) and in humans (Krssak et al. 1999; Petersen and Shulman 2006).”
BackgroundMolecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Self-citationDeficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 6×
“According to one hypothetical sequence, mitochondrial dysfunction mediates insulin resistance by impairing the oxidation within muscle tissue of fatty acids, which accumulate together with their derivatives as intramyocellular lipids (IMCLs); IMCLs then impair the transduction of the insulin signal, causing insulin re…”
BackgroundInfluentialBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · cited 3×
“…and function of skeletal muscle mitochondria showed normal function at the pre-diabetes stage (after 4 weeks) contrasting with dysfunction (complex I-linked respiration and b-oxidation) and increased oxidative stress at the stage of established diabetes (after 16 weeks) (Bonnard et al. 2008).”
BackgroundInfluentialMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 3×
“2004)—had a 38% lower mitochondrial density than did insulin-sensitive controls (Morino et al. 2005).”
BackgroundCalorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans
Civitarese, A. E., Carling, S., Heilbronn, L. K., Hulver, M. H., Ukropcova, B., Deutsch, W. A., Smith, S. R., & Ravussin, E. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040076 · Cited by 790
Sparks, L. M., Xie, H., Koza, R. A., Mynatt, R., Hulver, M. W., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1926 · Cited by 629 · cited 2×
“…G C 1α P G C 1α Metabolic reprogramming inhibits β-ox Metabolic reprogramming activates β-ox LIVER MUSCLE PANCREAS CPT2 T Blood vessel Blood vessel genes were downregulated, and the decreases in corresponding mRNAs and proteins were far larger than in human volunteers (Sparks et al. 2005).”
BackgroundMitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573 · cited 1×
“The other study compared mitochondrial respiration rates in isolated mitochondria from T2D patients and obese non-diabetic controls (Mogensen et al. 2007).”
BackgroundPGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550 · cited 1×
“In humans with T2D, the ability of insulin to inhibit hepatic gluconeogenesis is impaired (Petersen and Shulman 2006); and in T2D animal models, liver PGC-1a expression is elevated (Herzig et al. 2001; Koo et al. 2004; Saltiel and Kahn 2001; Yoon et al. 2001).”
BackgroundExcess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520 · cited 1×
“In various rodent models of insulin resistance induced by a high-fat diet, the skeletal muscle was characterized by upregulation of fatty acid oxidative capacity and of protein expression of PGC-1a and mitochondrial respiratory chain subunits (Turner et al. 2007).”
BackgroundMitochondrial function in normal and diabetic β-cells
Maechler, P., & Wollheim, C. B. (2001) · Nature · doi:10.1038/414807a · Cited by 519
Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?
Guarente, L. (2008) · Cell · doi:10.1016/j.cell.2008.01.007 · Cited by 513
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Li, X., Monks, B., Ge, Q., & Birnbaum, M. J. (2007) · Nature · doi:10.1038/nature05861 · Cited by 487 · cited 2×
“Peroxisome proliferator-activated receptor g co-activator 1a (PGC- 1a) is the main stimulant of hepatic gluconeogenesis (Herzig et al. 2001; Saltiel and Kahn 2001; Yoon et al. 2001) and is inhibited by insulin ( Li et al. 2007; Puigserver et al. 2003; Yoon et al. 2001).”
BackgroundStump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332551100 · Cited by 477
Maassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s103 · Cited by 439
Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways
A., K., & J., P. (2002) · Diabetologia · doi:10.1007/s00125-002-0974-7 · Cited by 438 · cited 1×
“Increased circulating insulin concentrations suppress the hepatic glucose output (Roden et al. 2001) and stimulate glucose uptake by skeletal muscle and adipose tissue ( Khan and Pessin 2002 ) (Fig. 1). The pathophysiological mechanisms leading to diabetes include inappropriate insulin secretion; insulin resistance of…”
BackgroundSilva, J. P., Köhler, M., Graff, C., Oldfors, A., Magnuson, M. A., Berggren, P.-O., & Larsson, N.-G. (2000) · Nature Genetics · doi:10.1038/81649 · Cited by 433
Pospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404 · cited 3×
“In the tissue-specific AIF knockout mouse model, decreases in complex I activity were noted in the AIF-deficient organ (muscle or liver), together with decreases in the expression of genes involved in oxidative phosphorylation (Pospisilik et al. 2007).”
BackgroundInfluentialSelf-citationToledo, F. G. S., Menshikova, E. V., Ritov, V. B., Azuma, K., Radikova, Z., DeLany, J., & Kelley, D. E. (2007) · Diabetes · doi:10.2337/db07-0141 · Cited by 321
Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291 · cited 1×
“Moreover, neither patients nor mouse models with inherited deficiencies in fatty acid oxidation exhibit muscle insulin resistance (Zhang et al. 2007).”
BackgroundPlasticity of skeletal muscle mitochondria: structure and function.
HOPPELER, H., & FL??CK, M. (2003) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200301000-00016 · Cited by 267
Richardson, D. K., Kashyap, S., Bajaj, M., Cusi, K., Mandarino, S. J., Finlayson, J., DeFronzo, R. A., Jenkinson, C. P., & Mandarino, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408985200 · Cited by 259
Garcia-Roves, P., Huss, J. M., Han, D.-H., Hancock, C. R., Iglesias-Gutierrez, E., Chen, M., & Holloszy, J. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704024104 · Cited by 246 · cited 1×
“Another study supplied additional evidence that fatty acids stimulated mitochondrial biogenesis via a posttranscriptionally mediated increase in PGC-1a (Garcia-Roves et al. 2007).”
BackgroundAsmann, Y. W., Stump, C. S., Short, K. R., Coenen-Schimke, J. M., Guo, Z., Bigelow, M. L., & Nair, K. S. (2006) · Diabetes · doi:10.2337/db05-1230 · Cited by 207 · cited 1×
“In a comparison of T2D patients and controls, the in vitro muscle mitochondrial ATP production rate was similar in the two groups at postabsorptive insulin levels, whereas at postprandial insulin levels it increased in the controls but not in the T2D patients (Asmann et al. 2006).”
Simmons, R. A., Suponitsky-Kroyter, I., & Selak, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505695200 · Cited by 194 · cited 1×
“Indeed, it has been established in animal models that intrauterine growth retardation induces mitochondrial dysfunction in the fetal b-cell, leading to increased production of reactive oxygen species, which in turn damage mitochondrial DNA (Simmons et al. 2005).”
BackgroundNair, K. S., Bigelow, M. L., Asmann, Y. W., Chow, L. S., Coenen-Schimke, J. M., Klaus, K. A., Guo, Z.-K., Sreekumar, R., & Irving, B. A. (2008) · Diabetes · doi:10.2337/db07-1556 · Cited by 187
Skeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803567 · Cited by 160 · cited 1×
“Rosiglitazone, a PPARg agonist belonging to the thiazolidinedione family, given for 8 weeks to T2D patients not only improved insulin sensitivity, but also restored normal levels of muscle PGC-1a mRNA, PPARd mRNA, and succinate dehydrogenase activity (Mensink et al. 2007).”
BackgroundRespiratory chain dysfunction in skeletal muscle does not cause insulin resistance
Wredenberg, A., Freyer, C., Sandström, M. E., Katz, A., Wibom, R., Westerblad, H., & Larsson, N.-G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.029 · Cited by 141 · cited 2×
“lowers blood glucose levels, and increases peripheral glucose uptake (Wredenberg et al. 2006).”
BackgroundDe Feyter, H. M., van den Broek, N. M. A., Praet, S. F. E., Nicolay, K., van Loon, L. J. C., & Prompers, J. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0756 · Cited by 116 · cited 5×
“Consistent with this argument, the transition from insulin resistance to T2D in diabetic fatty rats occurred despite normal muscle mitochondrial function (De Feyter et al. 2008b).”
BackgroundMethodResultInfluentialMisu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0489-8 · Cited by 102
On the role of uncoupling protein-2 in pancreatic beta cells
Affourtit, C., & Brand, M. D. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.022 · Cited by 78
Hoeks, J., Briedé, J. J., de Vogel, J., Schaart, G., Nabben, M., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.013 · Cited by 63 · cited 2×
“This study indicates that muscle fat accumulation can occur despite normal intrinsic mitochondrial function (Hoeks et al. 2008).”
BackgroundMitochondrial diabetes and its lessons for common Type 2 diabetes
Maassen, J. A., 't Hart, L. M., Janssen, G. M. C., Reiling, E., Romijn, J. A., & Lemkes, H. H. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340819 · Cited by 38
Maassen, J. A., Jahangir Tafrechi, R. S., Janssen, G. M. C., Raap, A. K., Lemkes, H. H., & ’t Hart, L. M. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.02.014 · Cited by 33 · cited 3×
“This later age of onset suggests a contribution of age-related processes to the gradual impairment of b-cell function (Maassen et al. 2006b).”
Background
Cited by
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Schapira, A. H. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61305-6 · Cited by 494
Segrè, A. V., DIAGRAM Consortium, MAGIC investigators, Groop, L., Mootha, V. K., Daly, M. J., & Altshuler, D. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001058 · Cited by 463
“However, it is still not clear whether the molecular and physiologic associations of mitochondria with diabetes are a cause or effect of the common form of T2D [1,2,12].”
BackgroundSkeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
Hesselink, M. K. C., Schrauwen-Hinderling, V., & Schrauwen, P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.104 · Cited by 242
Metadata
- Authors
- Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2009-10-11
- Volume
- 32
- Issue
- 6
- Pages
- 684-698
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2164548243
- Cited by
- 34
- References
- 44
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.